SCHEMBL12216369

SCHEMBL12216369

CCCCCc1ccc(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c(-c2cccc(CC(=O)O)c2)c1

nearest known ligand 0.90

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SELP P16109 2/20 0.90
▸ SELPLG Q14242 1/20 0.90
▸ PPARG P37231 2/20 0.51
▸ PPARD Q03181 2/20 0.51
▸ PPARA Q07869 2/20 0.51
▸ PTPN1 P18031 1/20 0.47
▸ SLC28A3 Q9HAS3 2/20 0.44
▸ ACHE P22303 1/20 0.44
▸ SLC5A1 P13866 1/20 0.44
▸ DYRK1A Q13627 1/20 0.43
▸ TYR P14679 1/20 0.43
▸ PTPN11 Q06124 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13390070 0.99 SELP (0.91) SELPSELPLGPPARGPPARDPPARA
SCHEMBL13056320 0.97 SELP (0.88) SELPSELPLGPPARGPPARDPPARA
SCHEMBL7619803 0.95 SELP (0.98) SELPSELPLGPPARGPPARDPPARA
SCHEMBL8205205 0.95 SELP (0.98) SELPSELPLGPPARGPPARDPPARA
Bimosiamose SCHEMBL14015902 0.95 SELP (1.00) SELPSELPLGPPARGPPARDPPARA
Bimosiamose SCHEMBL2529148 0.95 SELP (1.00) SELPSELPLGPPARGPPARDPPARA
Bimosiamose SCHEMBL12182030 0.95 SELP (1.00) SELPSELPLGPPARGPPARDPPARA
SCHEMBL7620761 0.95 SELP (1.00) SELPSELPLGPPARGPPARDPPARA
Bimosiamose SCHEMBL29372538 0.95 SELP (1.00) SELPSELPLGPPARGPPARDPPARA
SCHEMBL7614341 0.95 SELP (1.00) SELPSELPLGPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039601-B1 Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane REVOTAR BIOPHARMACEUTICALS AG (DE) 2011-10-18 — — US disclosed
Send feedback